MedPath

Youcare Pharmaceutical Group Co.,Ltd.

Ownership
-
Established
2001-08-14
Employees
3.1K
Market Cap
-
Website
www.youcareyk.com
Introduction

The company was founded in 2001 and is headquartered in Beijing. It is a pharmaceutical group enterprise integrating research and development of new drugs, drug production, distribution and sales. On December 24, 2020, Yuekang Pharmaceutical was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The company's main business covers the entire pharmaceutical R&D, manufacturing, distribution and sales industry chain. The company's core products are ginkgo biloba extract injections, omeprazole enteric capsules, metformin hydrochloride extended-release tablets, etc. Corporate honors: China's top 100 pharmaceutical industry enterprises, nationally certified enterprise technology center, 2020 China's best pharmaceutical R&D product line industrial enterprise, etc.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

163

NMPA:163

Drug Approvals

Ganciclovir for Injection

Product Name
注射用更昔洛韦
Approval Number
国药准字H20258058
Approval Date
Apr 7, 2025
NMPA

Omeprazole Enteric Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20056577
Approval Date
Nov 5, 2024
NMPA

Sulfmethoxazole,Trimethoprim,Boneol and Artificial Cow-bezoar Tablets

Product Name
磺啶冰黄片
Approval Number
国药准字H11022559
Approval Date
Nov 5, 2024
NMPA

Bismuth Potassium Citrate Granules

Product Name
枸橼酸铋钾颗粒
Approval Number
国药准字H20045466
Approval Date
Oct 22, 2024
NMPA

Vitamin C Chewable Tablets

Product Name
维生素C咀嚼片
Approval Number
国药准字H20054590
Approval Date
Oct 16, 2024
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20094019
Approval Date
Aug 12, 2024
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20094017
Approval Date
Aug 12, 2024
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20094018
Approval Date
Aug 12, 2024
NMPA

Clindamycin Hydrochloride Capsules

Product Name
盐酸克林霉素胶囊
Approval Number
国药准字H20194072
Approval Date
Jul 22, 2024
NMPA

Carbocysteine Tablets

Product Name
羧甲司坦片
Approval Number
国药准字H20194047
Approval Date
May 29, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.